New mesh shows promise for fixing stomach hernias

NCT ID NCT04282720

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small pilot study tested a biological mesh called SurgiMend during laparoscopic hiatal hernia repair in 9 adults. The goal was to see if the mesh helps prevent the hernia from coming back and improves quality of life. Participants were followed for 6 months with X-rays and surveys.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SurgiMend biological mesh
What this could lead to
If successful, this mesh could reduce hernia recurrence and improve quality of life after hiatal hernia repair.
What could go wrong
This is a very small pilot study with only 9 participants and no comparison group, so results may not apply to everyone. The mesh is made from animal tissue, which could cause allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIATAL HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kettering Health Network - Grandview Medical Center

    Dayton, Ohio, 45405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.